Partners in research: Benefits of a summer research program

Journal of Cancer Education

Volumn 21, Issue 4, 2007, Pages 243-247

  Kelly, Thomas ^a   Coleman, Elizabeth Ann ^a   Fifer, E Kim ^a   Burns, E Robert ^a   Orr, Clifton ^a   Nicholas, Richard W ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICAN AMERICAN; ARTICLE; CANCER RESEARCH; EDUCATION PROGRAM; EXPERIENCE; FOLLOW UP; FUNDING; HEALTH CARE ORGANIZATION; HUMAN; MEDICAL STUDENT; PRIORITY JOURNAL; SOCIAL WORK; UNITED STATES;

BIOMEDICAL RESEARCH; CAREER CHOICE; EDUCATION, MEDICAL, UNDERGRADUATE; HUMANS; MEDICAL ONCOLOGY;

EID: 34250881727     PISSN: 08858195     EISSN: None     Source Type: Journal    
DOI: 10.1080/08858190701347853     Document Type: Article

References (15)

1. The Arkansas cancer plan 2001-2005: A framework for action. http://www.healthyarkansas.com/disease/cancerplan.pdf. Accessed August 30, 2005.
2. Fang G, Kim CN, Perkins CL, et al. CGP57148B (STI-571) induces differentiation and apoptosis and sensitizes Bcr-Abl-positive human leukemia cells to apoptosis due to antileukemic drugs. Blood. Sep 15 2000;96(6):2246- 2253.
3. Cohen MH, Williams G, Johnson JR, et al. Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia. Clin Cancer Res. May 2002;8(5):935-942.
4. Huang M, Dorsey JF, Epling-Burnette PK, et al. Inhibition of Bcr-Abl kinase activity by PD180970 blocks constitutive activation of Stat5 and growth of CML cells. Oncogene. Dec 12 2002; 21(57):8804-8816.
5. Silver RT, Peterson BL, Szatrowski TP, et al. Treatment of the chronic phase of chronic myeloid leukemia with an intermittent schedule of recombinant interferon alfa-2b and cytarabine: results from CALGB study 9013. Leuk Lymphoma. Jan 2003;44(1):39-48.
6. Dei Tos AP. The reappraisal of gastrointestinal stromal tumors: from Stout to the KIT revolution. Virchows Arch. May 2003;442(5):421-428.
7. Sorlie T, Perou CM, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A. Sep 11 2001;98(19):10869-10874.
8. Sorlie T, Tibshirani R, Parker J, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A. Jul 8 2003;100(14):8418-8423.
9. Bertucci F, Viens P, Hingamp P, Nasser V, Houlgatte R, Birnbaum D. Breast cancer revisited using DNA array-based gene expression profiling. Int J Cancer. Feb 20 2003;103(5):565-571.
10. Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature. Aug 17 2000;406(6797):747-752.
11. Lander ES, Linton LM, Birren B, et al. Initial sequencing and analysis of the human genome. Nature. Feb 15 2001;409(6822):860-921.
12. Zhan F, Barlogie B, Shaughnessy J, Jr. Toward the identification of distinct molecular and clinical entities of multiple myeloma using global gene expression profiling. Semin Hematol. Oct 2003;40(4):308-320.
13. Blehar MC, Strete C. The National Cancer Institute's Cancer Education (R25E) Grants Program: an update. J Cancer Educ. Summer 2005;20(2):67-69.
14. Gronemeyer SA. The impact of predoctoral pediatric oncology education. J Cancer Educ. Spring 2005;20(1):16-22.
15. Michalek AM, Johnson CR. Cancer research training for high school and college students at a comprehensive cancer center. J Cancer Educ. Winter 2004;19(4):209-211.